… plasma expression of protein candidates belonging to the regulated pathways identified by
plasma TMT proteomic analysis in … as regulated in the proteomic analysis comparing WT and …

… Among the T2D patients, 40 individuals were treated with metformin and here we stratified
these into three groups based on the response of therapeutic intervention, as determined by …

… We previously identified new molecular plasma signatures for cardiovascular risk stratification
… Proteomic analysis was performed in plasma samples obtained from different age groups, …

… heterogeneous disease group. We aimed to measure and validate differences in plasma …
with idiopathic or heritable pulmonary arterial hypertension to improve risk stratification. …

… techniques, the risk score we constructed, based on 1461 proteins, stratified risk trajectories
well for … Proteomics analysis may therefore have great promise as an alternative to complex …

… samples underwent one freeze–thaw cycle to aliquot 120 μl for proteomic analysis and
provide other aliquots for NT-proBNP and targeted assays. Clinical and biochemical data were …

… Our evaluation encompassed multiple metrics, such as sensitivity, specificity, and ROC
values, which reflected the accuracy of our approach in disease classification. Proteomic …

… platforms as a strategy for risk stratification of renal disease. As advancing laboratory …
Summary Evaluation Reviewer 2 In this study the authors performed proteomic analysis of plasma …

… To identify proteomic profiles related to CV disease risk in a cohort of subjects aged 30–50 …
a multi-proteomics study. These analyses allowed us to carry out a deep proteomics analysis, …

… clinical plasma biomarkers for the diagnosis and stratification cardiovascular diseases that
… in technologies for proteomic analysis of the human plasma proteome and their applications …